Diabetes News and Research

Latest Diabetes News and Research

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

The Neurobiotechnology research team of the Universitat Jaume I in Castellón, Spain, headed by professor Ana María Sánchez, has proven the positive effects of a vegetable hormone, helping reverse brain alterations caused by high-fat diets, type-2 diabetes, obesity and physical inactivity.

3 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

Addressing social and cultural factors is key to reducing burden of type 2 diabetes

New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors.

From Novo Nordisk 3 Oct 2018

Gene variant linked to Type 2 diabetes may predispose people to have lower body weight

A research team at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health found that a well-known gene variant linked to Type 2 diabetes, called transcription Factor-7 like 2 gene, may also predispose someone to being leaner, or having a lower body weight.

3 Oct 2018

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

The natural world often provides the answer to unsolved medical problems. On this occasion, the solution to a challenge posed by cancer has come about from the immune system of camelids.

3 Oct 2018

Pesticides used in food, tobacco products place children and smokers in potential risk

Pesticides used in food, tobacco and marijuana production are placing children and smokers in potential risk, a study has found.

3 Oct 2018

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers used continuous glucose monitoring to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin.

3 Oct 2018

Feds settle huge whistleblower suit over Medicare Advantage fraud

One of the nation's largest dialysis providers will pay $270 million to settle a whistleblower's allegation that it helped Medicare Advantage insurance plans cheat the government for several years.

1 Oct 2018

Mediterranean diet cuts risk of developing AMD

Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration, a leading cause of blindness in the United States.

1 Oct 2018

Genetic variants reveal novel therapeutic targets for chronic kidney disease

The kidney does more than double or even triple duty compared to other organs - it extracts waste, balances body fluids, forms urine, regulates blood pressure, and secretes hormones.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

New insights into application of drug-eluting stents during percutaneous coronary intervention

Researchers at the Thorax Centrum Twente of Medisch Spectrum Twente and the University of Twente have recently completed their fourth major study into the application of drug-eluting stents during percutaneous coronary intervention.

1 Oct 2018

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.

29 Sep 2018

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption - where there is consumption, there is cancer.

29 Sep 2018

Diabetes UK Professional Conference 2019 to take place at ACC Liverpool

Registration to the 21st edition of Diabetes UK’s Professional Conference is now open, with the conference set to take place from Wednesday 6 March to Friday 8 March of next year at the Arena and Convention Centre Liverpool.

29 Sep 2018

Ethicon demonstrates commitment to improve access to life-changing obesity treatment

Ethicon, part of Johnson & Johnson Medical Devices Companies, demonstrates its commitment to improving access to life-changing obesity treatment and putting the most appropriate surgical tools in surgeons hands at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic Diseases.

29 Sep 2018

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.

28 Sep 2018

Diabetes News and Research

Latest Diabetes News and Research

Newly discovered compounds may explain whole grain health benefits

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

Addressing social and cultural factors is key to reducing burden of type 2 diabetes

Gene variant linked to Type 2 diabetes may predispose people to have lower body weight

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

Pesticides used in food, tobacco products place children and smokers in potential risk

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Feds settle huge whistleblower suit over Medicare Advantage fraud

Mediterranean diet cuts risk of developing AMD

Genetic variants reveal novel therapeutic targets for chronic kidney disease

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

New insights into application of drug-eluting stents during percutaneous coronary intervention

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

Cancer undercuts ability of normal cells to consume glucose, finds study

Diabetes UK Professional Conference 2019 to take place at ACC Liverpool

Ethicon demonstrates commitment to improve access to life-changing obesity treatment

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in